Invention Grant
- Patent Title: Nanoparticulate carverdilol formulations
- Patent Title (中): 纳米颗粒carverdilol制剂
-
Application No.: US11363266Application Date: 2006-02-28
-
Publication No.: US08367112B2Publication Date: 2013-02-05
- Inventor: Gary Liversidge , Scott Jenkins
- Applicant: Gary Liversidge , Scott Jenkins
- Applicant Address: IE Dublin
- Assignee: Alkermes Pharma Ireland Limited
- Current Assignee: Alkermes Pharma Ireland Limited
- Current Assignee Address: IE Dublin
- Agency: Foley & Lardner LLP
- Main IPC: A61K9/14
- IPC: A61K9/14 ; A61K9/16
Abstract:
The present invention is directed to nanoparticulate carvedilol compositions having improved pharmacokinetic profiles, improved bioavailability, dissolution rates and efficacy. In one embodiment, the nanoparticulate carvedilol composition has an effective average particle size of less than about 2000 nm.
Public/Granted literature
- US20070202180A1 Nanoparticulate carverdilol formulations Public/Granted day:2007-08-30
Information query
